Your browser doesn't support javascript.
loading
An update on molecular features and therapeutic perspectives of pediatric classical Hodgkin Lymphoma. What the clinician needs to know?
Simonin, Mathieu; Jardin, Fabrice; Leblanc, Thierry; Latour, Sylvain; Landman Parker, Judith.
Affiliation
  • Simonin M; Department of Pediatric Hematology and Oncology, AP-HP, Armand Trousseau Hospital, Sorbonne University, Paris, France; Laboratory of Normal and Pathological Lymphoid Differentiation, Institut Necker Enfants Malades (INEM), INERM UMR1151, Paris, France; Laboratory of Lymphocyte Activation and Suscept
  • Jardin F; Department of Hematology, Center Henri Becquerel, University of Rouen, INSERM UMR1245, Rouen, France.
  • Leblanc T; Department of Pediatric Hematology, AP-HP, Robert Debré Hospital, University Paris Diderot, Paris, France.
  • Latour S; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR1163, Imagine Institute, Paris, France; Université de Paris, Paris, France.
  • Landman Parker J; Department of Pediatric Hematology and Oncology, AP-HP, Armand Trousseau Hospital, Sorbonne University, Paris, France.
Eur J Med Genet ; 66(1): 104672, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36423786

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Agents Limits: Adult / Child / Humans Language: En Journal: Eur J Med Genet Journal subject: GENETICA MEDICA Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Agents Limits: Adult / Child / Humans Language: En Journal: Eur J Med Genet Journal subject: GENETICA MEDICA Year: 2023 Document type: Article